AURO LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of AURO LABORATORIES have decreased by -64.34% YoY .
The Earnings Per Share (EPS) of AURO LABORATORIES has increased by 92.20 % YoY. |
||
AURO LABORATORIES Last 5 Annual Financial Results
[BOM: 530233]
| Standalone | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹19 Cr | ₹54 Cr | ₹53 Cr | ₹5,087 Cr | ₹54,252 Cr |
| Expenses | ₹16 Cr | ₹43 Cr | ₹49 Cr | ₹4,624 Cr | ₹43,010 Cr |
| Operating Profit (Excl OI) | ₹3.13 Cr | ₹11 Cr | ₹4.39 Cr | ₹463 Cr | ₹11,242 Cr |
| Other Income | ₹0.93 Cr | ₹1.50 Cr | ₹0.94 Cr | ₹109 Cr | ₹758 Cr |
| Interest | ₹1.08 Cr | ₹0.74 Cr | ₹0.81 Cr | ₹83 Cr | ₹458 Cr |
| Depreciation | ₹1.10 Cr | ₹1.09 Cr | ₹1.07 Cr | ₹102 Cr | ₹1,036 Cr |
| Profit Before Tax | ₹1.88 Cr | ₹10 Cr | ₹3.45 Cr | ₹387 Cr | ₹10,505 Cr |
| Profit After Tax | ₹1.84 Cr | ₹7.79 Cr | ₹2.44 Cr | ₹284 Cr | ₹7,180 Cr |
| Earnings Per Share (Rs) | ₹5.67 | ₹2.95 | ₹12.50 | ₹3.92 | ₹4.56 |
| PAT Margin (%) | 11.49 | 9.61 | 14.53 | 4.62 | 5.59 |
| ROE(%) | 7.91 | 4.33 | 20.46 | 7.43 | 9.47 |
| ROCE(%) | 9.17 | 3.79 | 20.37 | 9.92 | 12.20 |
| Total Debt/Equity(x) | 1.37 | 1.05 | 0.63 | 0.19 | 0.44 |
Key Financials |
||
| Market Cap | : | ₹ 151.2 Cr |
| Revenue (TTM) | : | ₹ 30.8 Cr |
| Net Profit(TTM) | : | ₹ 3.5 Cr |
| EPS (TTM) | : | ₹ 5.7 |
| P/E (TTM) | : | 42.8 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| AURO LABORATORIES | 0.9% | -4.6% | -16.7% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.8% | 3.5% | 14.7% |
| DIVIS LABORATORIES | -1% | 7.3% | 7.6% |
| TORRENT PHARMACEUTICALS | -0.9% | 10.1% | 44.6% |
| CIPLA | -2.1% | -1.8% | -6% |
| DR REDDYS LABORATORIES | -5.8% | -13.2% | -7.7% |
| MANKIND PHARMA | -2.4% | 1.2% | -3.2% |
| LUPIN | -4.4% | 0.1% | 22.5% |
| ZYDUS LIFESCIENCES | -3.3% | 0.9% | 13.4% |
AURO LABORATORIES Revenues
[BOM: 530233]
| Y-o-Y | -64.34 % |
| 5 Yr CAGR | -86.30 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹19 Cr | -64.34 | |
| Mar2025 | ₹54 Cr | 1.40 | |
| Mar2024 | ₹53 Cr | -98.96 | |
| Mar2023 | ₹5,087 Cr | -90.62 | |
| Mar2022 | ₹54,252 Cr | - | |
AURO LABORATORIES Operating Profit
[BOM: 530233]
| Y-o-Y | -70.67 % |
| 5 Yr CAGR | -87.08 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.13 Cr | -70.67 | |
| Mar2025 | ₹11 Cr | 142.89 | |
| Mar2024 | ₹4.39 Cr | -99.05 | |
| Mar2023 | ₹463 Cr | -95.89 | |
| Mar2022 | ₹11,242 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -17.75 % |
| 5 Yr CAGR | -5.74 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 16.36% | -17.75 | |
| Mar2025 | 19.89% | 139.35 | |
| Mar2024 | 8.31% | -8.58 | |
| Mar2023 | 9.09% | -56.13 | |
| Mar2022 | 20.72% | - | |
AURO LABORATORIES Profit After Tax
[BOM: 530233]
| Y-o-Y | -76.40 % |
| 5 Yr CAGR | -87.35 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.84 Cr | -76.40 | |
| Mar2025 | ₹7.79 Cr | 219.08 | |
| Mar2024 | ₹2.44 Cr | -99.14 | |
| Mar2023 | ₹284 Cr | -96.04 | |
| Mar2022 | ₹7,180 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 19.56 % |
| 5 Yr CAGR | 19.74 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 11.49 % | 19.56 | |
| Mar2025 | 9.61 % | -33.86 | |
| Mar2024 | 14.53 % | 214.50 | |
| Mar2023 | 4.62 % | -17.35 | |
| Mar2022 | 5.59 % | - | |
AURO LABORATORIES Earnings Per Share (EPS)
[BOM: 530233]
| Y-o-Y | 92.20 % |
| 5 Yr CAGR | 5.60 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.67 | 92.20 | |
| Mar2025 | ₹2.95 | -76.40 | |
| Mar2024 | ₹13 | 218.88 | |
| Mar2023 | ₹3.92 | -14.04 | |
| Mar2022 | ₹4.56 | - | |
AURO LABORATORIES Return on Capital Employed (ROCE)
[BOM: 530233]
| Y-o-Y | 141.95 % |
| 5 Yr CAGR | -6.89 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 9.17% | 141.95 | |
| Mar2025 | 3.79% | -81.39 | |
| Mar2024 | 20.37% | 105.34 | |
| Mar2023 | 9.92% | -18.69 | |
| Mar2022 | 12.2% | - | |
AURO LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹243.9 |
| Current MarketCap | : | ₹ 151.2 Cr |
| Updated EOD on | : | Jul 24,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AURO LABORATORIES | 0.9% |
-4.6% |
-16.7% |
| SENSEX | -2.7% |
-0.2% |
-8% |
AURO LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about AURO LABORATORIES Financials
How the annual revenues of AURO LABORATORIES have changed ?
The Revenues of AURO LABORATORIES have decreased by -64.34% YoY .
How the Earnings per Share (EPS) of AURO LABORATORIES have changed?
The Earnings Per Share (EPS) of AURO LABORATORIES has increased by 92.20 % YoY .
Check out Intrinsic Value of Peers of AURO LABORATORIES
Compare Stock Analytics of Peers of AURO LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
